BiomX Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Selling, General & Admin	8.65	9.46	11.27	9.32	8.72	3.36	2.54	0.62
Research & Development	16.7	16.24	22.68	19.42	13.49	9.14	4.18	1.15
Other Operating Expenses	0	1.52	1.52	1.52	0	0	0	0
Operating Expenses	25.35	27.22	35.46	30.26	22.21	12.5	6.71	1.77
Operating Income	-25.35	-27.22	-35.46	-30.26	-22.21	-12.5	-6.71	-1.77
Interest Expense / Income	2.4	2.07	0.7	0	0	0.23	-0.28	-0
Other Expense / Income	-1.61	-1.04	-0	-0.17	-1.64	-	-	0.13
Pretax Income	-26.15	-28.25	-36.16	-30.09	-20.56	-12.72	-6.43	-1.9
Income Tax	0.02	0.07	0.07	0	0	0	0	0
Net Income	-26.17	-28.32	-36.23	-30.09	-20.56	-12.72	-6.43	-1.9
Shares Outstanding (Basic)	51	30	26	23	6	2	2	2
Shares Outstanding (Diluted)	51	30	26	23	6	2	2	2
Shares Change	71.94%	14.79%	12.77%	310.66%	180.45%	1.77%	0.23%	-
EPS (Basic)	-0.51	-0.95	-1.39	-1.30	-3.66	-7.62	-3.76	-1.01
EPS (Diluted)	-0.51	-0.95	-1.39	-1.30	-3.66	-7.62	-3.76	-1.01
Free Cash Flow	-21.34	-29.2	-31.25	-25.46	-18.89	-11.44	-4.95	-1.43
Free Cash Flow Per Share	-0.42	-0.98	-1.20	-1.10	-3.36	-5.71	-2.52	-0.73
EBITDA	-22.87	-23.66	-32.9	-27.91	-20.25	-12.29	-6.62	-1.88
Depreciation & Amortization	0.87	2.52	2.57	2.18	0.32	0.21	0.1	0.02
EBIT	-23.74	-26.18	-35.46	-30.09	-20.56	-12.5	-6.71	-1.9

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).